Hexarelin
A potent growth hormone releasing peptide that also binds a heart receptor (CD36). Its growth hormone effect fades with steady use.
- Evidence
- Limited human research
- Half-life
- Short
- Sources
- 2 cited
Is hexarelin FDA-approved?
Not approved by the FDA. Products sold online as "research chemicals" aren't checked for purity, sterility or dose.
Is hexarelin banned in sport?
Banned in sport by the World Anti-Doping Agency (WADA).
Overview
Hexarelin is a relative of GHRP-6 that causes a strong growth hormone release. Studies found the response weakens with long-term use and recovers after stopping. It also binds CD36 in heart tissue, and small human and animal studies point to heart effects separate from growth hormone.
How it works
It switches on the ghrelin receptor (growth hormone release) and CD36 (heart and blood vessels).
How long does hexarelin stay in the body?
Short; not well established.
What it's studied for
- Growth hormone release
- Heart function
Reported side effects
- Higher cortisol and prolactin
- Weaker effect over time
Related: GHRP-6, MK-677 (Ibutamoren), GHRP-2, Mecasermin (IGF-1).
Sources
The studies and prescribing labels this page is written from.
- The cardiovascular action of hexarelin. J Geriatr Cardiol, 2014 PubMed
- Does desensitization to hexarelin occur? Growth Horm IGF Res, 1998 PubMed